Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Navigating Evolving Challenges in Blood Safety
- Pourkarim M.R. , et al.
2. Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study
- Safarnezhad Tameshkel F. , et al.
3. Safety and Efficacy of Direct Acting Antivirals for Hepatitis C Virus Infection in Thalassemic Patients and Its Effect on Transfusion Requirements
- Naguib G.G. , et al.
4. Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
- Younas S. , et al.
5. Codon usage of human hepatitis C virus clearance genes in relation to its expression
- Singh P. , et al.
6. Real-life efficacy of generic sofosbuvir/ledipasvir for treatment of Iranian patients with chronic hepatitis C: A cohort study
- Sharafi H. , et al.
7. The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A longitudinal, prospective study
- Kamal S. , et al.
8. A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms
- Alavian S. , et al.
9. Psychiatric side effects of pegylated interferon-α and ribavirin therapy in iranian patients with chronic hepatitis c: A meta-analysis
- Davoodi L. , et al.
10. The effectiveness of sofosbuvir and daclatasvir in the treatment of hepatitis C in thalassaemia major patients and their effect on haematological factors
- Zamani F. , et al.
11. Efficacy and safety of generic sofosbuvir/ledipasvir fixed-dose combination in Iranian patients with chronic hepatitis C virus infection
- Sharafi H. , et al.
12. Assessment of hepatitis C virus RNA in peripheral blood mononuclear cells as a predictor of response to pegylated-interferon and ribavirin: A cohort study
- Miri S. , et al.
13. Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation
- Shinoda M. , et al.
14. Next steps toward eradication of hepatitis C in the era of direct acting antivirals
- Hesamizadeh K. , et al.